Company Filing History:
Years Active: 1995
Title: Helle Brondsted: Innovator in Colonic-Targeted Drug Delivery
Introduction
Helle Brondsted is an accomplished inventor based in Salt Lake City, Utah, known for her innovative contributions to the field of drug delivery systems. With a focus on colonic-targeted oral dosage forms, her work is at the forefront of advancing medical therapeutics.
Latest Patents
Helle holds one patent titled "Colonic-targeted oral drug-dosage forms based on crosslinked hydrogels." This invention revolves around drug formulations encapsulated within crosslinked hydrogels designed to release therapeutic agents selectively in the colon. The hydrogel's pH-dependent swelling mechanism allows for optimal drug release facilitated by the enzymatic cleavage of azobonds present in the structure. This innovative approach has the potential to enhance the effectiveness of drug delivery in treating gastrointestinal conditions.
Career Highlights
Helle Brondsted works with the University of Utah Research Foundation, where she applies her expertise in polymer chemistry and drug formulation. Her pioneering research continues to push the boundaries of pharmaceutical innovations, contributing significantly to enhanced therapeutic strategies.
Collaborations
Throughout her career, Helle has collaborated with esteemed colleagues, including Jindrich Henry Kopecek and Sung Wan Kim. These partnerships have bolstered her research efforts, allowing for cross-disciplinary insights and advancements in drug delivery technologies.
Conclusion
Helle Brondsted is a prominent figure in the realm of pharmaceuticals, particularly in the development of colonic-targeted drug delivery systems. Her patent showcases her innovative approach to drug formulation, bridging the gap between scientific research and practical medical applications. As advancements in this field continue to evolve, Helle's work is set to play a crucial role in enhancing patient care and treatment outcomes.